Eli

From FeedX

Enter your search terms Web feedx.net Submit search form

• Jonah Edwin Gregory Emmanuel Giovanni Eli Raymond Erick Wesley Trenton* Jonah Edwin Gregory Emmanuel Giovanni Eli Raymond Erick Wesley Trenton

• Neuz'eli tak vsio' ploho?

6 October 2008, by Neuz'eli tak vsio' ploho?

• Перед открытием фондового рынка: индексы ожидает обвал.[M]

6 October 2008, by Корпоративные новости: фармацевтическая компания Eli Lilly заявила о покупке биотехнологической компании ImClone, производящей антираковый препарат Erbitux, за $6 млрд.

• 3000 взаимных френдов для ЖЖ

6 October 2008, by friend add eli_d

• Посчитали - прослезились

6 October 2008, by Eli Stone

• Американский производитель лекарств Eli Lilly купит конкурента ImClone за $6,5 ...

6 October 2008, by Совет директоров биотехнологической компании ImClone Systems Inc, производителя лекарства от рака Erbitux, одобрил сделку по слиянию с фармацевтической компанией Eli Lilly and Co, отклонив улучшенное предложение другого конкурента - Bristol-Myers Squibb Co. Eli Lilly предложила $70 за акцию ImClone, оценив всю компанию в $6,5 млрд., что на 51% вые текущей рыночной капитализации по состоянию на 30 [

• Eli Lilly agrees to buy ImClone for $6.5 billion - International Herald Tribune

6 October 2008, by

• 16:15 -- Eli Lilly приобретет ImClone за 6,5 млрд долл. [РБК]

6 October 2008, by Советы директоров американской фармацевтической компании Eli Lilly and Co. и биотехнологической компании ImClone Systems Incorporated одобрили сделку по приобретению компанией Eli Lilly компании ImClone. Как сообщается в пресс-релизе Eli Lilly, цена за акцию составит 70 долл.

• Eli Lilly приобретет ImClone за 6,5 млрд долл.

6 October 2008, by

• Stock of the Day for October 06, 2008: Eli Lilly and Company (LLY)

6 October 2008, by unknown In a market plagued by tight credit and bankruptcies, pharmaceutical giant, Eli Lilly and Company, has agreed to acquire ImClone Systems Inc (IMCL: Charts, News, Offers) for $6.5 billion in an all cash deal that would expand its ...

• Eli Lilly to buy ImClone for more than $6B - The Associated Press

6 October 2008, by

• ELI Launches Top Teaching and Learning Challenges Survey

6 October 2008, by pkurkowski ELI Logo Assessment. Learning space design. Changing student and faculty practice. When polled, focus groups within the EDUCAUSE teaching and learning community identified their top “challenges” in teaching and learning with IT. ...

• aaaa, eto vi prosto ploho iskali)) nu ili eli tolko v turisticheskih mestah )

6 October 2008, by aaaa, eto vi prosto ploho iskali)) nu ili eli tolko v turisticheskih mestah ) v ...

• 2008美国达人（America’s got Talent）冠军揭晓

6 October 2008, by 2008美国达人（America’s got Talent）最终决出冠亚军， 胖子Neal E Boyd战胜灵魂歌者Eli Mattson 摘得桂冠。 由于美国达人的字幕版出的不是很紧，而我的半吊子英语还不足以听懂那么多的abcd，因此也没有狠追这个SHOW，但是对于这个SHOW还是很关注，其实相对于《美国偶像》的纯粹选拔歌手来说，《美国达人》选材的不拘一格会让你看到更多的身怀绝技的人们（不过也看到了很多很呕的人）。 首先说说这个冠军Neal E Boyd，不知道是不是巧合，不能不说这一季的冠军和上一季的《英国达人》的冠军Paul Potts实在是有太多相似之处，他们都是胖子，都是推销员（一个是卖手机的，一个是卖保险的），都来自社会底层，最主要的一点，是他们的才能都是号称高雅艺术的歌剧，而且他们最拿手的一首歌都是图兰朵的经典曲目《今夜无人入睡》，这不能不让人怀疑老天爷是不是在玩我们啊。(*+﹏+*)~ @~在这一刻他不是一个人在战斗，他是Paul Potts灵魂附体。↖(^ω^)↗ Neal E Boyd夺冠的视频 Paul Potts的经典瞬间 再来说说咱们

• От: eli-2008

6 October 2008, by Никому не понять любовь. супер вообще.я ща се копирую и выучу.мысли умные.и ...

• Eli and Edythe Broad Stage - Westside Today

6 October 2008, by

• Lilly Puts Up $6.5 Billion for ImClone

6 October 2008, by Lilly broke the news this morning that ImClone had accepted its offer to acquire the biotech firm for $6.5 billion or $70 per share—Lilly’s largest acquisition ever. With this purchase Lilly gains control of ImClone’s blockbuster, targeted cancer agent Erbitux, which is marketed for second- and third-line colon cancer and refractory head and neck cancer. ImClone also has five monoclonal antibodies in clinical development—including one in Phase III and two currently moving out of Phase II tr

• Lilly bids $6.5 billion for ImClone

6 October 2008, by BOSTON (Reuters) - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history. Klik her for læse hele nyheden

• Lilly bids $6.5 billion for ImClone

6 October 2008, by BOSTON (Reuters) - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history. Cliccare qui per leggere l’intero articolo

• Lilly bids $6.5 billion for ImClone

6 October 2008, by BOSTON (Reuters) - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history. Klik her for læse hele nyheden

• Eli Lilly 'Aa3' rating on review for downgrade - Hemscott

6 October 2008, by

• ... erexa piti tunavorvi, vor mi 20 or axmuk hanen u heto hangist eli sharunaken pox

6 October 2008, by Voch miayn ayd erkrum:) Nestlen, vory dirqavorvum e vorpes lavaguyn mankakan ...

• Square Eyes 6-9 October

6 October 2008, by Place of Execution (Monday 9pm, ITV1) This excellent, mature drama comes to an end as documentary journalist Catherine Heathcote (Juliet Stevenson) gets closer to the truth about what really happened to young Alison in 1963. As you’d expect from a drama based on a Val McDermid story, there are twists and turns galore before the final ten minutes, and the shocks keep coming right to the very end. ITV should be justifiably proud of putting out this superb piece that ticks all the right boxes - a

• Square Eyes 6-9 October

6 October 2008, by Place of Execution (Monday 9pm, ITV1) This excellent, mature drama comes to an end as documentary journalist Catherine Heathcote (Juliet Stevenson) gets closer to the truth about what really happened to young Alison in 1963. As you’d expect from a drama based on a Val McDermid story, there are twists and turns galore before the final ten minutes, and the shocks keep coming right to the very end. ITV should be justifiably proud of putting out this superb piece that ticks all the right boxes - a

• Eli Lilly agrees to buy ImClone for more than $6B

6 October 2008, by INDIANAPOLIS (AP) — Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand Lilly’s cancer treatment pipeline a few years before several patent expirations hit the drug maker…. Klik hier voor het volledige verhaal

• Eli Lilly Outbids Bristol-Myers for Imclone (LLY)

6 October 2008, by At this point, it seems as though Eli Lilly (LLY) will be the winner in the battle for Imclone Systems (IMCL). Lilly was able to outbid Bristol-Myers Squibb, which held a 17% stake in ImClone, and had recently raised its offer price to $62 a share. Lilly’s offer is for $70 per share in cash. The big prize that Lilly coveted was Erbitux, Imclone’s signature drug, which is used to treat colorectal, head and neck, and lung cancers. The product had sales of about $1.3 billion in 2007. ImClone also

• Notable Mergers and Acquisitions of the Day 10/06: IMCL/LLY, VSH...

6 October 2008, by Notable Mergers and Acquisitions of the Day 10/06: IMCL/LLY, VSH... StreetInsider.com News Articles Mon, 10/06/2008 - 08:49 ImClone Systems (NASDAQ: IMCL) entered into a merger agreement with Eli Lilly and Company (NYSE: LLY), pursuant to which Lilly has agreed to commence a tender offer for no less than a majority of the issued and outstanding shares of ImClone common stock at a net price per share of $70 in cash. The offer represents a $8 premium to Bristol-Myers Squibb's (NYSE: BMY) propos

• Quick Hits: Eli Lilly Snaps Up Imclone

6 October 2008, by unknown Eli Lilly (LLY) will acquire ImClone Systems (IMCL) for $70 per share or about $6.5 billion in cash.The price is about 7.7% above Friday’s close and about 51% above the stock price in July before Bristol-Myers announced its takeover bid ...

• Eli Lilly Buys Cancer Drug Maker ImClone; Carl Icahn Boosts Ego

6 October 2008, by Someone needs to make a movie about Carl Icahn. The all-star corporate raider is at it again. Icahn, who chairs the notorious pharmaceutical company ImClone’s board, has accepted a $70/share buyout of the company. From Reuters: Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, potentially bringing to a close one of the most colorful corporate sagas in biotech history. The deal, announced by the companies on Monday, values ImClone at $70 per share, a premium of 51

• Eli Lilly Buys Cancer Drug Maker ImClone; Carl Icahn Boosts Ego

6 October 2008, by Drea “We feel that the Eli Lilly transaction vindicates our decision to oppose in 2006 a potential transaction in which the company would have been sold at approximately $36 per share which the prior board favored,” Mr Icahn said. ...

• Un correcaminos pide hueco en el Málaga

6 October 2008, by Eliseu Pereira se reivindicó en el partido de ayer entre el Recreativo de Huelva y el Málaga, en el que el equipo de Antonio Tapia logró imponerse con un contundente 0-4. La gran figura del encuentro fue un portugués hasta ahora muy poco conocido en España: Edison Pereira. El rápido atacante luso se caracterizó la [...]